Cyclic diarylboron derivatives as NLRP3 inflammasome inhibitors

University of Manchester 2017. Cyclic diarylboron derivatives as NLRP3 inflammasome inhibitors. WO/2017/017469. [Patent].

Full text not available from this repository.

Abstract

Inhibitor compounds are disclosed. The compounds are effective in the treatment of diseases or conditions in which interleukin 1 β activity is implicated. Methods of synthesis of the compounds, as well as pharmaceutical compositions comprising the compounds are also disclosed.

Item Type:	Patent
Date Type:	Publication
Status:	Published
Schools:	Schools > Biosciences
Publisher:	WO Patent
Last Modified:	23 Oct 2022 13:13
URI:	https://orca.cardiff.ac.uk/id/eprint/110005

Actions (repository staff only)

Edit Item